Ascendis Pharma (ASND) Hurry and Set the Alarm Clock for 9:00 a.m. ET on Thursday!

Jul 30, 2015 - SmallCap Network

Ascendis Pharma A/S (ASND) ASND said that it will report before the market opens on Thursday top-line results from a Phase 2 pediatric study of once-weekly TransCon Growth Hormone ASND will host a conference call on July 30, 2015, at 9:00 a.m. Eastern Time to discuss the top-line results. Growth hormone deficiency, or GHD, is a serious orphan disease affecting both children … (continue reading)

Would you like to track this news?

Click one of the buttons below or search.

Advanced Options | Search Tips